Literature DB >> 17664024

Molecular mechanism of schizophrenia with reference to disrupted-in-schizophrenia 1 (DISC1).

Shinsuke Matsuzaki1, Masaya Tohyama.   

Abstract

Disrupted-in-schizophrenia 1 (DISC1) is a gene disrupted by a (1:1) (q42.1;q14.3) translocation that segregates with major psychiatric disorders in a Scottish family. To elucidate how DISC1 confers susceptibility to psychiatric disorders, identification of the molecules, which bind to the domain close to the translocation breakpoint in the DISC1 gene, was performed and fasciculation and elongation protein zeta-1 (Fez1), a novel DISC1-interacting protein, termed DISC1-binding zinc-finger protein (DBZ) and Kendrin were identified. The DISC1-Fez1 interaction is up-regulated by nerve growth factor (NGF) and involved in neurite extension. Transient dissociation of the DISC1-DBZ interaction by pituitary adenylate cyclase-activating polypeptide (PACAP) causes neurite extension. Furthermore, single-nucleotide polymorphisms association studies in a Japanese population have shown the relation of the Fez1, PACAP and PACAP receptor (PAC1) genes to schizophrenia. In schizophrenia with DISC1 translocation carrier, the DISC1-Fez1 and DISC1-DBZ interaction is disrupted, and it is likely that neural circuit formation remains immature, suggesting that schizophrenia is a neurodevelopmental disease. On the other hand, the DISC1-Kendrin interaction is suggested to be involved in microtubule network formation and an association between single-nucleotide polymorphisms of the Kendrin gene and bipolar disease has also been suggested in a Japanese population. This demonstrates that a part of bipolar disease is also a neurodevelopmental disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664024     DOI: 10.1016/j.neuint.2007.06.018

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

Review 1.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

2.  Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo.

Authors:  Lee E Eiden; Babru Samal; Matthew J Gerdin; Tomris Mustafa; David Vaudry; Nikolas Stroth
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

3.  Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.

Authors:  Inna Gaisler-Salomon; Gretchen M Miller; Nao Chuhma; Sooyeon Lee; Hong Zhang; Farhad Ghoddoussi; Nicole Lewandowski; Stephen Fairhurst; Yvonne Wang; Agnès Conjard-Duplany; Justine Masson; Peter Balsam; René Hen; Ottavio Arancio; Matthew P Galloway; Holly M Moore; Scott A Small; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-06-10       Impact factor: 7.853

4.  Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.

Authors:  David Delotterie; Geoffrey Ruiz; Jacques Brocard; Annie Schweitzer; Corinne Roucard; Yann Roche; Marie-Françoise Suaud-Chagny; Karine Bressand; Annie Andrieux
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

Review 5.  Schizophrenia: from genes to phenes to disease.

Authors:  Charlotte L Allan; Alastair G Cardno; Peter McGuffin
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

6.  PACAP38/PAC1 signaling induces bone marrow-derived cells homing to ischemic brain.

Authors:  Chen-Huan Lin; Lian Chiu; Hsu-Tung Lee; Chun-Wei Chiang; Shih-Ping Liu; Yung-Hsiang Hsu; Shinn-Zong Lin; Chung Y Hsu; Chia-Hung Hsieh; Woei-Cherng Shyu
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

Review 7.  Pericentrin in cellular function and disease.

Authors:  Benedicte Delaval; Stephen J Doxsey
Journal:  J Cell Biol       Date:  2009-12-01       Impact factor: 10.539

8.  A Review on the Expression Pattern of Non-coding RNAs in Patients With Schizophrenia: With a Special Focus on Peripheral Blood as a Source of Expression Analysis.

Authors:  Soudeh Ghafouri-Fard; Reyhane Eghtedarian; Mohammad Taheri; Annette Beatrix Brühl; Dena Sadeghi-Bahmani; Serge Brand
Journal:  Front Psychiatry       Date:  2021-06-18       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.